Aeolus Pharmaceuticals, Inc. (AOLS)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 2, 2026
Aeolus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2011 - 2007 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '17 Jun 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 | Sep '13 Sep 30, 2013 | Sep '12 Sep 30, 2012 | 2011 - 2007 |
| Cash & Equivalents | 0.4 | 3.16 | 0.09 | 1.52 | 0.87 | 0.28 | Upgrade
|
| Cash & Short-Term Investments | 0.4 | 3.16 | 0.09 | 1.52 | 0.87 | 0.28 | Upgrade
|
| Cash Growth | -89.27% | 3256.38% | -93.80% | 74.57% | 209.25% | -45.75% | Upgrade
|
| Receivables | 0.31 | 0.75 | 1.59 | 1.56 | 0.37 | 0.78 | Upgrade
|
| Prepaid Expenses | 0.05 | 0.23 | 0.05 | 0.05 | 0.04 | 0.06 | Upgrade
|
| Other Current Assets | - | - | 0.02 | 0.43 | 0.66 | 0.1 | Upgrade
|
| Total Current Assets | 0.76 | 4.14 | 1.75 | 3.55 | 1.93 | 1.22 | Upgrade
|
| Long-Term Investments | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Total Assets | 0.79 | 4.17 | 1.78 | 3.58 | 1.97 | 1.26 | Upgrade
|
| Accounts Payable | 0.59 | 0.97 | 1.6 | 1.55 | 0.58 | 2.17 | Upgrade
|
| Short-Term Debt | - | - | 1 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | 0.02 | 0.44 | 0.68 | 0.11 | Upgrade
|
| Total Current Liabilities | 0.59 | 0.97 | 2.62 | 2 | 1.26 | 2.27 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 19.32 | Upgrade
|
| Total Liabilities | 0.59 | 0.97 | 2.62 | 2 | 1.26 | 21.59 | Upgrade
|
| Common Stock | 1.52 | 1.52 | 1.36 | 1.36 | 1.35 | 0.63 | Upgrade
|
| Additional Paid-In Capital | 191.95 | 191.86 | 184.42 | 184.22 | 183.28 | 159.75 | Upgrade
|
| Retained Earnings | -193.26 | -190.19 | -186.63 | -184 | -183.92 | -180.71 | Upgrade
|
| Total Common Equity | 0.21 | 3.2 | -0.85 | 1.58 | 0.7 | -20.34 | Upgrade
|
| Shareholders' Equity | 0.21 | 3.2 | -0.85 | 1.59 | 0.71 | -20.34 | Upgrade
|
| Total Liabilities & Equity | 0.79 | 4.17 | 1.78 | 3.58 | 1.97 | 1.26 | Upgrade
|
| Total Debt | - | - | 1 | - | - | - | Upgrade
|
| Net Cash (Debt) | 0.4 | 3.16 | -0.91 | 1.52 | 0.87 | 0.28 | Upgrade
|
| Net Cash Growth | -89.27% | - | - | 74.57% | 209.25% | -45.75% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.02 | -0.01 | 0.01 | 0.01 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 152.09 | 152.09 | 135.93 | 135.85 | 134.55 | 62.73 | Upgrade
|
| Total Common Shares Outstanding | 152.09 | 152.09 | 135.93 | 135.85 | 134.55 | 62.73 | Upgrade
|
| Working Capital | 0.18 | 3.16 | -0.88 | 1.55 | 0.67 | -1.05 | Upgrade
|
| Book Value Per Share | 0.00 | 0.02 | -0.01 | 0.01 | 0.01 | -0.32 | Upgrade
|
| Tangible Book Value | 0.21 | 3.2 | -0.85 | 1.58 | 0.7 | -20.34 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | 0.02 | -0.01 | 0.01 | 0.01 | -0.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.